| Stalpex 50 microgram/500 microgram/dose inhalation powder, pre-dispensed PA22815/001/001 |
Salmeterol, Fluticasone propionate |
Glenmark Pharmaceuticals Nordic AB |
— |
| STAMICIS 1mg kit for radiopharmaceutical preparation PA0677/018/001 |
Tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate |
CIS bio International |
Marketed |
| STAYVEER 125 mg film-coated tablets EU/1/13/832/002 |
Bosentan monohydrate |
Janssen Pharmaceutica NV |
— |
| STAYVEER 62.5 mg film-coated tablets EU/1/13/832/001 |
Bosentan monohydrate |
Janssen Pharmaceutica NV |
— |
| Steglatro 15 mg film-coated tablets EU/1/18/1267/007-012 |
Ertugliflozin l-pyroglutamic acid |
Merck Sharp & Dohme BV |
— |
| Steglatro 5 mg film-coated tablets EU/1/18/1267/001-006 |
Ertugliflozin l-pyroglutamic acid |
Merck Sharp & Dohme BV |
— |
| Steglujan 15 mg/100 mg film-coated tablets EU/1/18/1266/007-012 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| Steglujan 5 mg/100 mg film-coated tablets EU/1/18/1266/001-006 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| STELARA 130 mg Concentrate for solution for infusion EU/1/08/494/005 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 45 mg Solution for injection EU/1/08/494/003 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 45 mg Solution for injection EU/1/08/494/001 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 90 mg Solution for injection EU/1/08/494/004 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STEQEYMA 130 mg Concentrate for solution for infusion EU/1/24/1844/003 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| STEQEYMA 45 mg Solution for injection EU/1/24/1844/001 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| STEQEYMA 90 mg Solution for injection EU/1/24/1844/002 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| Sterile Dopamine Concentrate BP 160mg/ml, 5ml PA0073/108/002 |
DOPAMINE HYDROCHLORIDE |
Mercury Pharmaceuticals (Ireland) Ltd |
Not marketed |
| Sterile Dopamine Concentrate BP 40mg/ml PA0073/108/001 |
DOPAMINE HYDROCHLORIDE |
Mercury Pharmaceuticals (Ireland) Ltd |
Not marketed |
| Stimufend 6 mg solution for injection in pre-filled syringe EU/1/22/1632/001 |
Pegfilgrastim |
Fresenius Kabi Deutschland GmbH |
— |
| Stivarga 40 mg film-coated tablets EU/1/13/858/001-002 |
Regorafenib |
Bayer Pharma AG |
— |
| Stoboclo 60 mg solution for injection in pre-filled syringe EU/1/24/1905/001 |
Denosumab |
Celltrion Healthcare Hungary Kft. |
— |
| Stocrin EU/1/99/111/003 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| Stocrin EU/1/99/111/004 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| STOCRIN EU/1/99/111/001 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| STOCRIN EU/1/99/111/002 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| STOCRIN 200 mg film-coated tablets EU/1/99/111/011 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| STOCRIN 30 mg/mL oral solution EU/1/99/111/005 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| STOCRIN 50 mg film-coated tablets EU/1/99/111/010 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| Stocrin Film-Coated EU/1/99/111/6-7 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| Stocrin Film-Coated EU/1/99/111/8-9 |
Efavirenz |
Merck Sharp & Dohme BV, |
— |
| Strensiq 100 mg/ml solution for injection EU/1/15/1015/003-004 |
Asfotase alfa |
Alexion Europe SAS |
— |
| Strensiq 40 mg/ml solution for injection EU/1/15/1015/001-002 |
Asfotase alfa |
Alexion Europe SAS |
— |
| Strepsils Intensive Honey & Eucalyptus Sugar Free 8.75 mg lozenges PA0979/080/001 |
Flurbiprofen |
Reckitt Benckiser Ireland Limited |
— |
| Striascan 74 MBq /mL solution for injection EU/1/19/1372/001-002 |
IOFLUPANE (1231) |
CIS bio International |
— |
| Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets EU/1/13/830/001 |
Emtricitabine, Tenofovir disoproxil, Cobicistat, Elvitegravir |
Gilead Sciences Ireland UC |
— |
| Strimvelis 1-10 x 10e6 cells/mL dispersion for infusion EU/1/16/1097/001 |
Autologous cd34+ enriched cell fraction |
Fondazione Telethon Ets |
— |
| Suboxone 12 mg/3 mg Sublingual film EU/1/06/359/016-018 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Indivior Europe Limited |
— |
| Suboxone 16 mg/4 mg Sublingual tablet EU/1/06/359/005-006 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Indivior Europe Limited |
— |
| Suboxone 2 mg/0.5 mg Sublingual film EU/1/06/359/007-009 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Indivior Europe Limited |
— |
| Suboxone 2 mg/0.5 mg Sublingual tablet EU/1/06/359/01-02 |
Naloxone, Buprenorphine |
Indivior Europe Limited |
— |
| Suboxone 4 mg/1 mg Sublingual film EU/1/06/359/010-012 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Indivior Europe Limited |
— |
| Suboxone 8 mg/2 mg Sublingual film EU/1/06/359/013-015 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Indivior Europe Limited |
— |
| Suboxone 8 mg/2 mg Sublingual tablet EU/1/06/359/03-04 |
Buprenorphine hydrochloride, NALOXONE HYDROCHLORIDE |
Indivior Europe Limited |
— |
| Sugammadex 100 mg/mL solution for injection PA23250/012/001 |
Sugammadex sodium |
MSN Labs Europe Limited |
Not marketed |
| Sugammadex Adroiq 100 mg/mL solution for injection EU/1/23/1733/001-002 |
Sugammadex sodium |
Extrovis EU Kft. |
— |
| Sugammadex Fresenius Kabi 100 mg/mL solution for injection EU/1/22/1663/001-003 |
Sugammadex |
Fresenius Kabi Deutschland GmbH |
— |
| Sugammadex Mylan 100 mg/mL solution for injection EU/1/21/1583/001-004 |
Sugammadex sodium |
Mylan Pharmaceuticals Limited |
— |
| Sugammadex Piramal 100 mg/mL solution for injection EU/1/23/1739/001-002 |
Sugammadex sodium |
Piramal Critical Care B.V. |
— |
| Sugammadex – Amomed® EU/1/22/1708/001 |
Sugammadex sodium |
Aop Orphan Pharmaceuticals GmbH |
— |
| Suliqua 100 units/ml + 33 micrograms/ml solution for injection in pre-filled pen EU/1/16/1157/003-004 |
Lixisenatide, Insulin glargine |
Sanofi-Aventis Groupe |
— |
| Suliqua 100 units/ml + 50 micrograms/ml solution for injection in pre-filled pen EU/1/16/1157/001-002 |
Insulin glargine, Lixisenatide |
Sanofi-Aventis Groupe |
— |